Indias Tax Administration Overhaul Planned for Seamless GST Rollout OpenAI IPO Filing Could Signal New Era for AI Companies in Public Markets Japanese Yen and Swiss Franc Gain as DeepSeek AI Model Sparks SafeHaven Rush NFL Seeks Ban on PlayerSpecific Prediction Market Contracts Citing Integrity Concerns Paul Tudor Jones No Chance Warsh Can Push Fed to Cut Rates Restaurant Adopts PayWhatYouWant Model as Diners Stay Home SKIL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher RITM Q1 2026 Earnings Modest EPS Beat Highlights Stability in Mortgage Real Estate Hillman Solutions HLMN Q1 2026 Earnings EPS Falls Short Amid Challenging Environment Spectral AI Inc MDAI Q1 2026 Earnings WiderThanExpected Loss Amid Absent Revenue Disclosure CZNC Q1 2026 Earnings Massive EPS Miss Shocks Analysts Stock Holds Steady FCF Q1 2026 Earnings EPS Misses Estimates by 857 amid Challenging Operating Environment ORIX Corporation ADS IX Faces Selling Pressure Testing Key Support Levels MicroVision Inc MVIS Faces Selling Pressure Holds Above Key Support Akamai Technologies Holds Steady Near Support Amid Modest Decline ServiceTitan TTAN Gains 3 as Stock Approaches Key Resistance Level Celsius Holdings CELH Surges Over 10 Can Momentum Sustain Above Key Levels JK Tyre Reports 80 Surge in Q4 Net Profit Announces Rs 4980 Crore Expansion Plan FrontView REIT FVR Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency Ecolab Inc ECL Edges Higher as Support Holds Focus Shifts to Key Resistance Quoin Pharmaceuticals Ltd Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Phase EE Q1 2026 Earnings EPS Misses Estimates Yet Shares Rise on Steady Operations SNSE Q1 2026 Earnings Massive EPS Miss Masks Potential Pipeline Milestones THM Q1 2026 Earnings Modest Profit Reported Amid No Revenue and Market Pullback EVTV Q4 2025 Earnings Significant Loss Reported Amidst Zero Revenue American Realty Investors ARL Q3 2024 Earnings Widening Loss Amid No Consensus Estimate PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response